Tibolone improves myocardial perfusion in postmenopausal women with ischemic heart disease: An open-label exploratory pilot study

Journal of the American College of Cardiology

Volumn 47, Issue 3, 2006, Pages 559-564

  Campisi, Roxana ^a,c   Camilletti, Jorge ^a   Mele, Aníbal ^a   Erriest, Juan ^a   Pedroni, Pablo ^a   Guiglioni, Ariel ^b  

^a Instituto de Cardiologia La Plata   (Argentina)

^b Centro de Reproducción Y Planificación Familiar   (Argentina)

^c Instituto de Cardiologia La Plata   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

TIBOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORPREGNENES; POSTMENOPAUSE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 31644435073     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.09.033     Document Type: Article

References (12)

1. G. Jackson Tibolone and the cardiovascular system Eur Heart J Suppl 3 2001 M17 M21
2. K. Kon Koh, A.J. Yeal, J.D. Kyu Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women Arterioscler Thromb Vasc Biol 23 2003 1889 1894
3. E. Cicinelli, L.J. Ignarro, P. Galantino Effects of tibolone on plasma levels of nitric oxide in postmenopausal women Fertil Steril 78 2002 464 468
4. G.W.L. Lloyd, N.R. Patel, E.A. McGing Acute effects of hormone replacement with tibolone on myocardial ischaemia in women with angina Int J Clin Pract 52 1998 155 157
5. R. Hachamovitch, D.S. Berman, H. Kiat Exercise myocardial perfusion SPECT in patients without known coronary artery disease Incremental prognostic value and use in risk stratification Circulation 93 1996 905 914
6. R. Schwartz, T.A. Pearson, V.G. Kalaria Prospective serial evaluation of myocardial perfusion and lipids during the first 6-months of pravastatin therapy J Am Coll Cardiol 42 2003 600 610
7. L. Johnson, S.A. Verdesca, W.Y. Aude Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms J Am Coll Cardiol 30 1997 1641 1648
8. K.F. Van Train, J. Areeda, E.V. Garcia Quantitative same-day rest-stress technetium-99m-sestamibi SPECT definition and validation of stress normal limits and criteria for abnormality J Nuc Med 34 1993 1494 1502
9. H.J. Kloosterboer Tibolone a steroid with tissue-specific mode of action J Steroid Biochem Mol Biol 76 2001 231 238
10. D. Hudita, C. Posea, I. Ceausu Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women Eur Rev Med Pharmacol Sci 7 2003 117 125
11. R. Campisi, L. Nathan, M. Hernandez-Pampaloni Noninvasive assessment of coronary microcirculatory function in postmenopausal women and of effects of acute and chronic estrogen administration Circulation 105 2002 425 430
12. R. Campisi, M.F. Di Carli Assessment of coronary flow reserve and microcirculation a clinical perspective J Nuc Cardiol 1 2004 3 11